LIVER NEOPLASMS
Clinical trials for LIVER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new LIVER NEOPLASMS trials appear
Sign up with your email to follow new studies for LIVER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to stop rare liver cancer from coming back
Disease control Not yet recruitingThis study tests whether combining an immunotherapy drug (cadonilimab) with a chemotherapy pill (capecitabine) can prevent a rare mixed liver cancer from returning after surgery. About 75 adults who had their tumor completely removed but are at medium-to-high risk of recurrence w…
Matched conditions: LIVER NEOPLASMS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
New ultrasound tech may spot chemo winners weeks sooner
Diagnosis Not yet recruitingThis study tests a new ultrasound method to see if it can predict whether chemotherapy is working for colorectal cancer that has spread to the liver. Standard scans take about 2 months to show results, but this ultrasound looks at blood flow inside the tumor after just 1-2 chemo …
Matched conditions: LIVER NEOPLASMS
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated May 20, 2026 12:08 UTC
-
New ultrasound may predict chemo results in weeks, not months
Knowledge-focused Not yet recruitingThis study tests a new ultrasound technique to see if it can predict whether chemotherapy is working for stomach cancer that has spread to the liver. Currently, doctors wait about 2 months for CT or MRI scans to show tumor changes. This ultrasound looks at blood flow inside the t…
Matched conditions: LIVER NEOPLASMS
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated May 26, 2026 03:18 UTC
-
Blood test may replace scans for liver cancer treatment monitoring
Knowledge-focused Not yet recruitingThis study looks at whether blood-based biomarkers can predict and monitor how well liver cancer responds to a standard treatment called TACE. Researchers will collect blood samples from 60 adults with liver cancer before and after TACE, then compare the results with CT or MRI sc…
Matched conditions: LIVER NEOPLASMS
Sponsor: University of Belgrade • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
1,000 patients to be tracked after liver surgery in new observational study
Knowledge-focused Not yet recruitingThis study will follow 1,000 adults who have liver or bile duct surgery at San Jacopo Hospital in Pistoia. Researchers will track complications, survival, and cancer recurrence for up to 5 years. The goal is to better understand how patients recover and their long-term outcomes a…
Matched conditions: LIVER NEOPLASMS
Sponsor: Azienda USL Toscana Centro • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC